Individuals Discontinuing Slimming Injections Gain Back Weight at a Quadrupled Rate Compared to Dieters

Fresh analysis reveals that patients who come off popular weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds far faster than those who end traditional diet and exercise regimens.

Findings released in a prominent health publication shows that while obese people can lose about a fifth of their body weight while undergoing treatment, the mass returns at an estimated rate of nearly a kilo each month upon discontinuation.

"Individuals purchasing these medications must be cognizant of the risk of rapid weight regain when the therapy concludes," cautioned lead investigator Dr. Susan Jebb.

That rate of recovery suggests a reversion to original mass in about one and a half years.

Analyzing Therapies

The analysis, which looked at 37 of trials involving thousands of patients, contrasted the results of the injectable medications with other pills.

The team emphasize that individuals who shed pounds through diet and exercise usually experience a slower creep back—approximately 0.1 kg a month—after stopping.

Understanding the Quick Regain

Nutrition scientists propose the way of the drugs is key to understanding the heightened regain.

These medications mimic a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Sustained high doses of GLP-1 levels several times higher than normal may cause the system to produce less of its endogenous GLP-1, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.

"Stopping of this hormone supplement leads to hunger is no longer kept in check, making excessive eating much more probable."

An Ongoing Issue?

Health authorities advise the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.

Professionals argue that, due to the likelihood of relapse, the treatment might need to be long-term.

This opinion is echoed by drug manufacturers, who say that the results "underscore the long-term nature of excess weight," akin to managing diseases like diabetes.

Patient Accounts

Users who have discontinued the medication describe a sudden resurgence of hunger.

"I experienced a switch that goes on and you become extremely hungry," recalled one woman.

The struggle is compounded if individuals have not developed sustainable dietary or behavioural modifications during therapy.

Growing Interest

Survey data show that millions of people in the UK have tried weight-loss jabs in the past year, with demand continuing to grow.

• Adoption is higher among women compared to males.
• The middle-aged age group shows the highest level of interest.
• Many obtain the medications through private prescriptions rather than the NHS.

Finally, researchers caution that while these medications are effective agents for weight loss, they are not a magic solution and maintained weight loss relies on combined behavioural management.